Haas Jason
CIK 1883821
Transactions on file
9
Open-market buys
1
Win rate (buys)
0%
1 scored
Avg % since filing (buys)
-19.0%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 2026-08-12 | LGND LIGAND PHARMACEUTICALS INC | Director | Sale | 7,138 | $2.09M | +3.7% | open → |
| 2026-08-14 | 2026-08-12 | LGND LIGAND PHARMACEUTICALS INC | Director | Exer. | 6,138 | $316.5K | +488.7% | open → |
| 2026-06-16 | 2026-06-12 | LGND LIGAND PHARMACEUTICALS INC | Director | Sale | 3,461 | $886.3K | +18.5% | open → |
| 2026-06-16 | 2026-06-12 | LGND LIGAND PHARMACEUTICALS INC | Director | Sale | 3,000 | $765.0K | +19.0% | open → |
| 2026-06-16 | 2026-06-12 | LGND LIGAND PHARMACEUTICALS INC | Director | Exer. | 1,000 | $51.6K | +488.7% | open → |
| 2026-06-16 | 2026-06-12 | LGND LIGAND PHARMACEUTICALS INC | Director | Exer. | 3,000 | $154.7K | +488.7% | open → |
| 2026-06-09 | 2026-06-05 | LGND LIGAND PHARMACEUTICALS INC | Director | Grant | 836 | $0.00 | — | open → |
| 2026-05-12 | 2026-05-08 | ODTX Odyssey Therapeutics, Inc. | Chief Financial Officer | Buy | 1,000 | $20.0K | -19.0% | open → |
| 2025-06-10 | 2025-06-06 | LGND LIGAND PHARMACEUTICALS INC | Director | Grant | 1,209 | $0.00 | — | open → |
